A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 494.85
C 33.92
GOOG 611.69
BAC 8.26
RIMM 15.99

Recently Added

CPIC 1.23
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.83

Gaining Speed

COHO 0.00
NBTH 12.50
SHMX 0.00
CPIC 1.23
AVEW 0.00
17.07 +0.60 (3.83%) AMLN

Click Here to Receive Instant E-mail and RSS Alerts


Trade AMLN now with

Stock Details

Last Trade:17.07 Change:+0.60 (3.83%) Prev Close:16.47 Open: 15.68 Days Range:15.60 – 17.08 52 Week Range: 8.03 - 18.30 Volume:4118225 P/E: N/A
EPS:-0.70

Member Comments

No member comments available for AMLN


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/09/12

Recent Alert on 02/07/12 at 7:40am
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance

Jefferies boosted its estimates and price target on Buy-rated Amylin Pharmaceuticals (NASDAQ: AMLN) from $25 to $30 following Q4 results, with guidance that suggests upside to sales estimates. The firm comments, "AMLN announced 4Q11 and issued... Read More

Recent Alert on 02/07/12 at 7:40am
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Recent Alert on 02/07/12 at 7:40am
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Recent Alert on 02/07/12 at 7:40am
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Recent Alert on 02/06/12 at 4:43pm
Amylin Pharma (AMLN) Reports Q4 GAAP Loss of $3.15/Share

View AllRecent Press Releases

Press Release on 02/09/12 at 9:00am
A Forward Look, the Year Ahead - Featured Research on BioMarin Pharmaceutical Inc. and Amylin Pharmaceuticals, Inc.
Press Release on 02/06/12 at 4:41pm
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results

View AllRecent SEC Filings

SEC Filing on 02/06/12 at 4:58pm
Form 8-K AMYLIN PHARMACEUTICALS For: Feb 06

View AllRecent Blog Posts

Blog Posts on 02/08/12 at 6:48pm
GlaxoSmithKline: A Good Mix Of Income And Opportunity
Blog Posts on 02/07/12 at 10:06am
Trading Biotech In Pairs: A Better Way To Hedge
Blog Posts on 02/03/12 at 4:09am
Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech
Blog Posts on 02/01/12 at 2:41pm
Lilly Has Earned Its Lousy Rep
Blog Posts on 01/27/12 at 3:21pm
Amylin Gets Its Yes; Now For The Hard Work